Congratulations to Drs. Irah King and Emerson Krock on their project, “Identifying cross-reactive antibody microbial targets and pain mechanisms in fibromyalgia.”
This research explores how alterations in the gut microbiome may drive the development of fibromyalgia, a chronic pain disorder that affects up to 8% of the population and remains without a clear cause or diagnostic test. The team will investigate how specific gut microbes can trigger immune responses that generate antibodies capable of inducing pain. By uncovering how these antibodies form and act, the study aims to pave the way for new diagnostic tools and targeted treatments that address immune and microbiome-related causes of fibromyalgia.